# Obsidian Therapeutics Inc. (OBX)

Source: https://www.quantisnow.com/company/OBX
Generated: 2026-11-11T10:53:47.230Z

- Ticker: OBX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0002130606

## About

Obsidian Therapeutics, Inc. is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered TIL cell therapies for the treatment of patients with solid tumors. Obsidian's proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs. Obsidian has offices in Cambridge and Bedford, MA. For more information, please visit www.obsidiantx.com.

## Latest OBX news and filings

No events on the wire yet.

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/OBX
- Earnings history: https://www.quantisnow.com/earnings/OBX
- Dividend history: https://www.quantisnow.com/dividends/OBX
- Insider transactions: https://www.quantisnow.com/insiders/OBX
- Options chain: https://www.quantisnow.com/options/OBX
- SEC 8-K filings only: https://www.quantisnow.com/company/OBX/8-k
- RSS and alerts for OBX: https://www.quantisnow.com/docs/rss-feeds.md